Li P - Search Results

1

Prognostic Significance of mRNA Expression RBBP8 or Its Methylation in Gliomas.

Liu Z, Cheng X, Lin S, Han Z, Jin H, Luan Z, Li P, Liang W, Qian R, Gao Y. Liu Z, et al. Among authors: li p. Cell Mol Neurobiol. 2023 Jan;43(1):409-422. doi: 10.1007/s10571-022-01198-4. Epub 2022 Feb 1. Cell Mol Neurobiol. 2023. PMID: 35106666

2

Effects of ESCO2 or its methylation on the prognosis, clinical characteristics, immune microenvironment, and pathogenesis of low-grade glioma.

Liu Z, Cheng X, Pang B, Wang S, Liu B, Cao C, Qian R, Liang W, Zhu Y, Li P, Gao Y. Liu Z, et al. Among authors: li p. Int Immunopharmacol. 2022 Mar;104:108399. doi: 10.1016/j.intimp.2021.108399. Epub 2022 Jan 8. Int Immunopharmacol. 2022. PMID: 35008004

3

CLSPN is a potential biomarker associated with poor prognosis in low-grade gliomas based on a multi-database analysis.

Jia Y, Cheng X, Liang W, Lin S, Li P, Yan Z, Zhang M, Ma W, Hu C, Wang B, Liu Z. Jia Y, et al. Among authors: li p. Curr Res Transl Med. 2022 Sep;70(4):103345. doi: 10.1016/j.retram.2022.103345. Epub 2022 Apr 26. Curr Res Transl Med. 2022. PMID: 35487167

4

DRAXIN as a Novel Diagnostic Marker to Predict the Poor Prognosis of Glioma Patients.

Jia Y, Liu Z, Cheng X, Liu R, Li P, Kong D, Liang W, Liu B, Wang H, Bu X, Gao Y. Jia Y, et al. Among authors: li p. J Mol Neurosci. 2022 Oct;72(10):2136-2149. doi: 10.1007/s12031-022-02054-2. Epub 2022 Aug 30. J Mol Neurosci. 2022. PMID: 36040678 Free PMC article.

5

ECM2, a prognostic biomarker for lower grade glioma, serves as a potential novel target for immunotherapy.

Cheng X, Liu Z, Liang W, Zhu Q, Wang C, Wang H, Zhang J, Li P, Gao Y. Cheng X, et al. Among authors: li p. Int J Biochem Cell Biol. 2023 May;158:106409. doi: 10.1016/j.biocel.2023.106409. Epub 2023 Mar 29. Int J Biochem Cell Biol. 2023. PMID: 36997057 Free article.

6

Exploring the relationship between abnormally high expression of NUP205 and the clinicopathological characteristics, immune microenvironment, and prognostic value of lower-grade glioma.

Liang W, Hu C, Zhu Q, Cheng X, Gao S, Liu Z, Wang H, Li P, Gao Y, Qian R. Liang W, et al. Among authors: li p. Front Oncol. 2023 May 22;13:1007198. doi: 10.3389/fonc.2023.1007198. eCollection 2023. Front Oncol. 2023. PMID: 37284202 Free PMC article.

7

ZNF480 influences the prognosis, pathogenesis, and immune microenvironment in patients with lower-grade glioma.

Zhu Q, Liu Z, Cheng X, Liang W, Wang H, Li P, Zhang J, Chen Y, Gao Y, Qian R. Zhu Q, et al. Among authors: li p. Heliyon. 2023 Jul 17;9(7):e18185. doi: 10.1016/j.heliyon.2023.e18185. eCollection 2023 Jul. Heliyon. 2023. PMID: 37519705 Free PMC article.

8

WD repeat domain 76 predicts poor prognosis in lower grade glioma and provides an original target for immunotherapy.

Cheng X, Liu Z, Chang H, Liang W, Li P, Gao Y. Cheng X, et al. Among authors: li p. Eur J Med Res. 2024 Jan 3;29(1):13. doi: 10.1186/s40001-023-01605-6. Eur J Med Res. 2024. PMID: 38173030 Free PMC article.

9

[Clinical characteristics of anti-CV2 antibody-associated neurological diseases].

Jia Y, Huang Y, Zhang JW, Zhu MF, Li PH, Wang LL, Shao WJ, Tan LL, Qin YH, Chen C. Jia Y, et al. Among authors: li ph. Zhonghua Yi Xue Za Zhi. 2021 Jul 20;101(27):2170-2172. doi: 10.3760/cma.j.cn112137-20210219-00432. Zhonghua Yi Xue Za Zhi. 2021. PMID: 34275254 Chinese.

10

Multivalent and synergistic chitosan oligosaccharide-Ag nanocomposites for therapy of bacterial infection.

Mei L, Xu Z, Shi Y, Lin C, Jiao S, Zhang L, Li P. Mei L, et al. Among authors: li p. Sci Rep. 2020 Jun 19;10(1):10011. doi: 10.1038/s41598-020-67139-7. Sci Rep. 2020. PMID: 32561796 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36,686 results

Search Page

Filters